Cytokine-mediated fibronectin production and transendothelial migration of lymphocytes in the mechanism of cardiac allograft vascular disease: efficacy of novel therapeutic approaches.
Rabinovitch
M
M
Division of Cardiovascular Research, Hospital for Sick Children, University of Toronto, Ontario, Canada.
Molossi
S
S
Clausell
N
N
D000818:Animals; D002199:Capillary Permeability / Q000502:physiology; D002465:Cell Movement / Q000502:physiology; D003324:Coronary Artery Disease / Q000473:pathology*; D003331:Coronary Vessels / Q000473:pathology; D016207:Cytokines / Q000378:metabolism*; D004730:Endothelium, Vascular / Q000473:pathology*; D005353:Fibronectins / Q000378:metabolism*; D006084:Graft Rejection / Q000473:pathology*; D016027:Heart Transplantation / Q000473:pathology*; D007124:Immunoenzyme Techniques; D009131:Muscle, Smooth, Vascular / Q000473:pathology; D011183:Postoperative Complications / Q000473:pathology*; D011817:Rabbits; D013552:Swine; D013601:T-Lymphocytes / Q000473:pathology*; D016042:Transplantation, Heterotopic; D014184:Transplantation, Homologous; D017539:Tunica Intima / Q000473:pathology
D016207:Cytokines; D005353:Fibronectins